Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04925245 · ClinicalTrials.gov registry record · NA

Clinical Reminder to Improve Appropriateness of Echocardiography

A NA study of Echocardiography, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
1,365
Enrollment target
1
Study location

NCT04925245: Completed NA study of Echocardiography, sponsored by Stanford University.

NCT04925245 is a NA study of Echocardiography that has completed, run by Stanford University. The registered enrollment target is 1,365 participants, above the 470-participant average among 4 other Echocardiography trials with a reported enrollment target (190% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04925245, a NA study of Echocardiography, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
1,365 participants
Enrollment target
1
Study location

Study Summary

This study will test a clinical reminder to show recent echocardiograms when a new echocardiogram is ordered. The goal is to avoid unnecessary comprehensive echocardiography.

Primary Outcome

Number of comprehensive echos completed

Conditions Studied

Interventions

  • OTHER Clinical Reminder

Study Locations (1)

California

  • Stanford Health Care - Stanford

Trial Details

FieldValue
Enrollment Target 1,365 participants
Start Date 2019-09-30
Est. Completion 2020-12-31
Phase NA
Stanford University

1,744 total trials

What the finished NCT04925245 record still lists

NCT04925245 is an interventional study that assigns participants to a tested intervention. Its 1,365 participants enrollment target places it among the larger protocols in the corpus, above the 470-participant average among 4 other Echocardiography trials with a reported enrollment target (190% higher).

The record links to 1 condition, with Echocardiography appearing as the primary indexed condition, and to 1 intervention - of which Clinical Reminder is the first listed.

NCT04925245 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04925245 about?

NCT04925245 is a clinical study titled "Clinical Reminder to Improve Appropriateness of Echocardiography". This study will test a clinical reminder to show recent echocardiograms when a new echocardiogram is ordered. The goal is to avoid unnecessary comprehensive echocardiography.

What is the current status of trial NCT04925245?

This trial is currently completed. It is a NA study. The enrollment target is 1,365 participants. The study started on 2019-09-30. Estimated completion is 2020-12-31.

What conditions does trial NCT04925245 study?

This clinical trial studies the following conditions: Echocardiography.

What interventions are being tested in trial NCT04925245?

The interventions under investigation include: Clinical Reminder (OTHER).

Who is sponsoring clinical trial NCT04925245?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04925245 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Echocardiography

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02677064 · 1,365 participants

    Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

  • NCT04489238 · 1,366 participants

    Collection of Information to Better Understand Young Onset Colorectal Cancer

  • NCT07256392 · 1,370 participants · Phase 3

    Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

  • NCT05245227 · 1,358 participants · Phase 3

    Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04925245, the US trial registry maintained by the National Library of Medicine. NCT04925245 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.